Thomas Hielscher

17PUBLICATIONS
115CO-AUTHORS
Haematological tumoursAerodynamics (excl. hypersonic aerodynamics)Predictive and prognostic markersGene and molecular therapyBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 13, 2026
Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy.

Jan H Frenking, Christine Riedhammer, Thomas Hielscher

|Oct 02, 2024
Glucocorticoids induce a maladaptive epithelial stress response to aggravate acute kidney injury.

Luping Zhou, Marc Torres Pereiro, Yanqun Li

|Jul 10, 2024
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation.

Manuela Hummel, Thomas Hielscher, Martina Emde-Rajaratnam

|Jun 27, 2024
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries.

Anja Seckinger, Hans Salwender, Hans Martin

|Jan 04, 2024
Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary.

Maria Pouyiourou, Tilmann Bochtler, Cornelia Coith

|Oct 24, 2023
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.

Maria Pouyiourou, Bianca N Kraft, Timothy Wohlfromm

Pageof 3

Frequent Collaborators

2 joint publications

Elias Karl Mai

2 joint publications

Christof Scheid

2 joint publications

Alwin Krämer

2 joint publications

Hartmut Goldschmidt